Financial results - MEDAXIM SRL

Financial Summary - Medaxim Srl
Unique identification code: 10953616
Registration number: J38/345/1998
Nace: 4532
Sales - Ron
41.071
Net Profit - Ron
-2.115
Employee
1
The most important financial indicators for the company Medaxim Srl - Unique Identification Number 10953616: sales in 2023 was 41.071 euro, registering a net profit of -2.115 euro and having an average number of 1 employees. Firma isi desfasoara activitatea in domeniul Comert cu amanuntul de piese si accesorii pentru autovehicule having the NACE code 4532.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Medaxim Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 242.062 106.548 101.122 114.441 91.107 72.828 25.441 95.128 110.726 41.071
Total Income - EUR 246.285 136.280 103.800 114.787 94.855 73.543 32.973 104.048 110.727 41.071
Total Expenses - EUR 253.756 154.107 105.287 111.649 101.666 70.801 39.726 92.915 109.561 43.186
Gross Profit/Loss - EUR -7.471 -17.827 -1.487 3.138 -6.812 2.742 -6.753 11.133 1.166 -2.115
Net Profit/Loss - EUR -7.471 -17.827 -1.487 2.012 -7.760 2.010 -7.195 10.093 58 -2.115
Employees 3 2 0 2 1 1 1 2 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales decreased by -62.8%, from 110.726 euro in the year 2022, to 41.071 euro in 2023. The Net Profit decreased by -58 euro, from 58 euro in 2022, to 0 in the last year.

Check the financial reports for the company - Medaxim Srl

Rating financiar

Financial Rating -
Medaxim Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Medaxim Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Medaxim Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Medaxim Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Medaxim Srl - CUI 10953616

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 70.290 42.435 34.906 53.629 37.765 28.666 24.029 11.693 9.947 9.805
Current Assets 106.554 54.312 46.304 44.415 40.070 44.654 62.294 70.325 58.508 56.456
Inventories 2.542 1.112 2.659 1.682 1.328 1.336 47.085 49.137 40.006 0
Receivables 43.901 29.988 31.112 32.126 26.354 19.298 14.075 16.805 6.398 53.750
Cash 60.111 23.212 12.533 10.606 12.389 24.019 1.134 4.383 12.104 2.707
Shareholders Funds 12.329 -5.395 -7.046 -4.915 -12.585 -10.331 -17.123 -6.651 -6.613 -8.708
Social Capital 45 45 45 44 43 42 248 243 243 243
Debts 164.515 102.141 88.255 102.958 90.419 83.651 103.446 88.669 75.068 74.969
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "4532 - 4532"
CAEN Financial Year 4532
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 56.456 euro in 2023 which includes Inventories of 0 euro, Receivables of 53.750 euro and cash availability of 2.707 euro.
The company's Equity was valued at -8.708 euro, while total Liabilities amounted to 74.969 euro. Equity decreased by -2.115 euro, from -6.613 euro in 2022, to -8.708 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Medaxim Srl

Comments - Medaxim Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.